Literature DB >> 19482623

Chemokines and angiogenesis in rheumatoid arthritis.

Zoltan Szekanecz1, Angela Pakozdi, Agnes Szentpetery, Timea Besenyei, Alisa E Koch.   

Abstract

In rheumatoid arthritis, chemokines mediate the migration of inflammatory leukocytes into the synovium. Among the four known chemokine families, CXC, CC chemokines and fractalkine seem to be of outstanding importance in this process. Angiogenesis, the formation of new vessels, is also important during the perpetuation of inflammation underlying rheumatoid arthritis. In this review, authors discuss the role of the most important chemokines and chemokine receptors in arthritis-associated neovascularization. The process and regulation of angiogenesis are described in this context as well. Apart from discussing the pathogenic role of chemokines and chemokine receptors in arthritic vessel formation, authors also review the important relevance of chemokines and angiogenesis for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19482623      PMCID: PMC2884394          DOI: 10.2741/E5

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  69 in total

Review 1.  Chemokine expression and regulation of angiogenesis in rheumatoid arthritis.

Authors:  E H Rudolph; J M Woods
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

2.  MCP-1 mediates TGF-beta-induced angiogenesis by stimulating vascular smooth muscle cell migration.

Authors:  Jing Ma; Qiang Wang; Teng Fei; Jing-Dong Jackie Han; Ye-Guang Chen
Journal:  Blood       Date:  2006-10-10       Impact factor: 22.113

3.  Antitumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms.

Authors:  A P Vicari; S Ait-Yahia; K Chemin; A Mueller; A Zlotnik; C Caux
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

Review 4.  Therapeutic angiogenesis for ischemic cardiovascular disease.

Authors:  S B Freedman; J M Isner
Journal:  J Mol Cell Cardiol       Date:  2001-03       Impact factor: 5.000

5.  Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicyclic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis.

Authors:  M V Volin; L A Harlow; J M Woods; P L Campbell; M A Amin; M Tokuhira; A E Koch
Journal:  Arthritis Rheum       Date:  1999-09

6.  Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis.

Authors:  Sofie Struyf; Marie D Burdick; Elke Peeters; Karolien Van den Broeck; Chris Dillen; Paul Proost; Jo Van Damme; Robert M Strieter
Journal:  Cancer Res       Date:  2007-06-15       Impact factor: 12.701

7.  Monocyte chemoattractant protein 1 and interleukin 8 production by rheumatoid synoviocytes. Effects of anti-rheumatic drugs.

Authors:  P Loetscher; B Dewald; M Baggiolini; M Seitz
Journal:  Cytokine       Date:  1994-03       Impact factor: 3.861

8.  Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis.

Authors:  Philippe Lesnik; Christopher A Haskell; Israel F Charo
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

9.  Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes.

Authors:  David K Jin; Koji Shido; Hans-Georg Kopp; Isabelle Petit; Sergey V Shmelkov; Lauren M Young; Andrea T Hooper; Hideki Amano; Scott T Avecilla; Beate Heissig; Koichi Hattori; Fan Zhang; Daniel J Hicklin; Yan Wu; Zhenping Zhu; Ashley Dunn; Hassan Salari; Zena Werb; Neil R Hackett; Ronald G Crystal; David Lyden; Shahin Rafii
Journal:  Nat Med       Date:  2006-04-30       Impact factor: 53.440

10.  CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer.

Authors:  Dingzhi Wang; Haibin Wang; Joanne Brown; Takiko Daikoku; Wei Ning; Qiong Shi; Ann Richmond; Robert Strieter; Sudhansu K Dey; Raymond N DuBois
Journal:  J Exp Med       Date:  2006-03-27       Impact factor: 14.307

View more
  17 in total

Review 1.  TLRs, future potential therapeutic targets for RA.

Authors:  Hatem A Elshabrawy; Abdul E Essani; Zoltán Szekanecz; David A Fox; Shiva Shahrara
Journal:  Autoimmun Rev       Date:  2016-12-15       Impact factor: 9.754

Review 2.  Cellular targeting in autoimmunity.

Authors:  Jennifer L Rogers; Donald S Serafin; Roman G Timoshchenko; Teresa K Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2012-12       Impact factor: 4.806

3.  Serum chemokines in patients with rheumatoid arthritis treated with etanercept.

Authors:  Piotr Adrian Klimiuk; Stanislaw Sierakowski; Izabela Domyslawska; Justyna Chwiecko
Journal:  Rheumatol Int       Date:  2009-12-19       Impact factor: 2.631

Review 4.  Chemokines in health and disease.

Authors:  Dayanidhi Raman; Tammy Sobolik-Delmaire; Ann Richmond
Journal:  Exp Cell Res       Date:  2011-01-09       Impact factor: 3.905

5.  Visfatin/pre-B-cell colony-enhancing factor (PBEF), a proinflammatory and cell motility-changing factor in rheumatoid arthritis.

Authors:  Florian M P Meier; Klaus W Frommer; Marvin A Peters; Fabia Brentano; Stephanie Lefèvre; Dirk Schröder; Diego Kyburz; Jürgen Steinmeyer; Stefan Rehart; Steffen Gay; Ulf Müller-Ladner; Elena Neumann
Journal:  J Biol Chem       Date:  2012-07-05       Impact factor: 5.157

6.  Anti-CXCL5 therapy ameliorates IL-17-induced arthritis by decreasing joint vascularization.

Authors:  Sarah R Pickens; Nathan D Chamberlain; Michael V Volin; Mark Gonzalez; Richard M Pope; Arthur M Mandelin; Jay K Kolls; Shiva Shahrara
Journal:  Angiogenesis       Date:  2011-07-21       Impact factor: 9.596

Review 7.  Targeting of proangiogenic signalling pathways in chronic inflammation.

Authors:  Sander W Tas; Chrissta X Maracle; Emese Balogh; Zoltán Szekanecz
Journal:  Nat Rev Rheumatol       Date:  2015-12-03       Impact factor: 20.543

8.  Angiogenesis in rheumatoid arthritis is fostered directly by toll-like receptor 5 ligation and indirectly through interleukin-17 induction.

Authors:  Seung-Jae Kim; Zhenlong Chen; Nathan D Chamberlain; Michael V Volin; William Swedler; Suncica Volkov; Nadera Sweiss; Shiva Shahrara
Journal:  Arthritis Rheum       Date:  2013-08

9.  Characterising the expression and function of CCL28 and its corresponding receptor, CCR10, in RA pathogenesis.

Authors:  Zhenlong Chen; Seung-Jae Kim; Abdul B Essani; Michael V Volin; Olga M Vila; William Swedler; Shiva Arami; Suncica Volkov; Latriese V Sardin; Nadera Sweiss; Shiva Shahrara
Journal:  Ann Rheum Dis       Date:  2014-05-15       Impact factor: 19.103

Review 10.  Recent paradigm shifts in the diagnosis and treatment of rheumatoid arthritis.

Authors:  Young Ok Jung; Hyun Ah Kim
Journal:  Korean J Intern Med       Date:  2012-11-27       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.